Promise of Eli Lilly’s weight-loss drug for sleep apnea adds one other purpose to bear the inventory

Eli Lilly‘s weight-loss drug Zepbound confirmed promise as a treatment for sleep apnea — giving traders more self belief to preserve proudly owning the sphere’s most treasured smartly being-care firm even after it is been crushing the S&P 500’s efficiency over the past three years.